Amgen (AMGN) Amortization - Intangibles (2009 - 2012)

Amgen (AMGN) recorded quarterly Amortization - Intangibles of $73.0 million in Q4 2012, down 1.35% quarter-over-quarter from $74.0 million in Q3 2012, and little changed on a YoY basis from $73.0 million in Q1 2012.

Amgen (AMGN) Amortization - Intangibles (2009 - 2012) Analysis & Trends

Amgen's Amortization - Intangibles history runs 4 years deep, the most recent figure standing at $73.0 million for Q4 2012.

  • In Q4 2012, Amortization - Intangibles changed 0.0% year-over-year to $73.0 million; the TTM figure through Dec 2012 stood at $294.0 million (changed 0.0% YoY), while the FY2012 annual figure was $294.0 million, changed 0.0% from the prior year.
  • Amortization - Intangibles was $73.0 million for Q4 2012 at Amgen, down from $74.0 million in the prior quarter.
  • In the past five years, Amortization - Intangibles ranged from a high of $74.0 million in Q1 2009 to a low of $73.0 million in Q2 2009.
  • Historically, Amortization - Intangibles has averaged $73.5 million across 4 years, with a median of $73.5 million in 2009.
  • Biggest YoY gain for Amortization - Intangibles was 0.0% in 2010; the steepest drop was 0.0% in 2010.
  • A 4-year view of Amortization - Intangibles shows it stood at $73.0 million in 2009, then changed by 0.0% to $73.0 million in 2010, then changed by 0.0% to $73.0 million in 2011, then changed by 0.0% to $73.0 million in 2012.
  • The last three Amortization - Intangibles figures came in at $73.0 million (Q4 2012), $74.0 million (Q3 2012), and $73.0 million (Q2 2012), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn
10 Novartis Ag 108.28 Bn 107.60 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2012 73.00 Mn
Sep 30, 2012 74.00 Mn
Jun 30, 2012 73.00 Mn
Mar 31, 2012 74.00 Mn
Dec 31, 2011 73.00 Mn
Sep 30, 2011 74.00 Mn
Jun 30, 2011 73.00 Mn
Mar 31, 2011 74.00 Mn
Dec 31, 2010 73.00 Mn
Sep 30, 2010 74.00 Mn
Jun 30, 2010 73.00 Mn
Mar 31, 2010 74.00 Mn
Dec 31, 2009 73.00 Mn
Sep 30, 2009 74.00 Mn
Jun 30, 2009 73.00 Mn
Mar 31, 2009 74.00 Mn